by François Vanhersecke and Stephen W. Brown, PhD
Volume 1, Issue 3 (Fall 2002)
This paper reviews the manufacturing of veterinary viral vaccines and discusses the industry regulatory frameworks in both the European Union and the United States, the world’s two largest regulatory markets. We also address specific technical and regulatory issues associated with viral vaccine inactivation. Finally, we present two case histories for conventional viral vaccines: Foot and Mouth Disease Virus (FMDV) and Marek’s Disease, which are both long-established conventional vaccines, but nevertheless of great interest…
Citation:
Vanhersecke F, Brown SW. Animal Viral Vaccine Manufacturing. BioProcess J, 2002; 1(3): 48-52.